ATE93721T1 - Verwendung von fluoxetin zur behandlung des diabetes. - Google Patents

Verwendung von fluoxetin zur behandlung des diabetes.

Info

Publication number: ATE93721T1
Authority: AT; Austria
Prior art keywords: fluoxetin; treat diabetes; diabetes; treat; fluoxetine
Prior art date: 1987-05-04

Application number

AT88303930T

Other languages

English (en)

Inventor

David Taiwai Wong

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-05-04

Filing date

1988-04-29

Publication date

1993-09-15

1988-04-29 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1993-09-15 Application granted granted Critical

1993-09-15 Publication of ATE93721T1 publication Critical patent/ATE93721T1/de

Links

206010012601 diabetes mellitus Diseases 0.000 title abstract 2
229960002464 fluoxetine Drugs 0.000 title abstract 2
RTHCYVBBDHJXIQ-UHFFFAOYSA-N N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine Chemical compound C=1C=CC=CC=1C(CCNC)OC1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-UHFFFAOYSA-N 0.000 title 1
RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Diabetes (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Plant Substances (AREA)

AT88303930T 1987-05-04 1988-04-29 Verwendung von fluoxetin zur behandlung des diabetes. ATE93721T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4550987A	1987-05-04	1987-05-04
EP88303930A EP0294028B1 (de)	1987-05-04	1988-04-29	Verwendung von Fluoxetin zur Behandlung des Diabetes

Publications (1)

Publication Number	Publication Date
ATE93721T1 true ATE93721T1 (de)	1993-09-15

Family

ID=21938301

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88303930T ATE93721T1 (de)	1987-05-04	1988-04-29	Verwendung von fluoxetin zur behandlung des diabetes.

Country Status (11)

Country	Link
EP (1)	EP0294028B1 (de)
JP (1)	JP2721507B2 (de)
KR (1)	KR880013555A (de)
AT (1)	ATE93721T1 (de)
AU (1)	AU596296B2 (de)
DE (1)	DE3883606T2 (de)
DK (1)	DK238588A (de)
ES (1)	ES2058272T3 (de)
HK (1)	HK19595A (de)
PH (1)	PH23901A (de)
ZA (1)	ZA883115B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0449562A3 (en) *	1990-03-29	1992-03-18	Eli Lilly And Company	Use of r-fluoxetine as selective serotonin ic-receptor ligands
US5589511A (en) *	1990-08-13	1996-12-31	Sepracor Inc.	Method for treating migraine headaches using optically pure S(+) fluoxetine
US5708035A (en) *	1991-02-04	1998-01-13	Sepracor Inc.	Methods of use and compositions of R(-) fluoxetine
US5459164A (en) *	1994-02-03	1995-10-17	Boots Pharmaceuticals, Inc.	Medical treatment
US7034059B2 (en)	2001-07-02	2006-04-25	Sepracor Inc.	Methods of using norfluoxetine
RU2350327C2 (ru)	2003-04-29	2009-03-27	Ориксиджен Серапьютикс, Инкорпорэйтд	Составы, вызывающие потерю веса
EP1951212A2 (de) *	2005-11-22	2008-08-06	Orexigen Therapeutics, Inc.	Zusammensetzungen und verfahren zur erhöhung der insulinsensitivität
US8916195B2 (en)	2006-06-05	2014-12-23	Orexigen Therapeutics, Inc.	Sustained release formulation of naltrexone
CA2668885C (en)	2006-11-09	2016-08-02	Orexigen Therapeutics, Inc.	Methods for administering weight loss medications
TW201811315A (zh)	2006-11-09	2018-04-01	美商歐瑞根治療有限公司	層狀醫藥調配物
EP2303025A4 (de)	2008-05-30	2012-07-04	Orexigen Therapeutics Inc	Verfahren zur behandlung von eingeweidefettbeschwerden
EP3659604A1 (de)	2010-01-11	2020-06-03	Nalpropion Pharmaceuticals, Inc.	Verfahren zur bereitstellung einer gewichtsverlusttherapie für patienten mit schweren depressionen
PT3730132T (pt)	2012-06-06	2022-08-16	Nalpropion Pharmaceuticals Llc	Composição para utilização num método de tratamento de excesso de peso e obesidade em doentes com alto risco cardiovascular
US20150190352A1 (en)	2012-07-31	2015-07-09	Sanovel Hayvan Sagligi Ürünleri Sanayi Ve Ticaret Anonim Sirketi	Use of fluoxetine in animals
WO2014021802A1 (en)	2012-07-31	2014-02-06	Sanovel Hayvan Sagligi Ürünleri Sanayi Ve Ticaret A.S.	Use of fluoxetine for increasing meat and milk production
US8969371B1 (en)	2013-12-06	2015-03-03	Orexigen Therapeutics, Inc.	Compositions and methods for weight loss in at risk patient populations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4626549A (en) *	1974-01-10	1986-12-02	Eli Lilly And Company	Treatment of obesity with aryloxyphenylpropylamines
US4018895A (en) *	1974-01-10	1977-04-19	Eli Lilly And Company	Aryloxyphenylpropylamines in treating depression
US4590213A (en) *	1983-04-08	1986-05-20	Eli Lilly And Company	Anti-anxiety method
CA1267092A (en) *	1985-02-25	1990-03-27	Martin D. Hynes	Analgesic composition containing codeine

1988
- 1988-04-29 PH PH36859A patent/PH23901A/en unknown
- 1988-04-29 AT AT88303930T patent/ATE93721T1/de not_active IP Right Cessation
- 1988-04-29 DE DE88303930T patent/DE3883606T2/de not_active Expired - Fee Related
- 1988-04-29 EP EP88303930A patent/EP0294028B1/de not_active Expired - Lifetime
- 1988-04-29 ES ES88303930T patent/ES2058272T3/es not_active Expired - Lifetime
- 1988-05-02 JP JP63109838A patent/JP2721507B2/ja not_active Expired - Lifetime
- 1988-05-02 ZA ZA883115A patent/ZA883115B/xx unknown
- 1988-05-03 DK DK238588A patent/DK238588A/da not_active Application Discontinuation
- 1988-05-03 AU AU15533/88A patent/AU596296B2/en not_active Ceased
- 1988-05-03 KR KR1019880005132A patent/KR880013555A/ko not_active Ceased
1995
- 1995-02-09 HK HK19595A patent/HK19595A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK238588D0 (da)	1988-05-03
DE3883606D1 (de)	1993-10-07
EP0294028B1 (de)	1993-09-01
EP0294028A2 (de)	1988-12-07
EP0294028A3 (en)	1990-05-02
KR880013555A (ko)	1988-12-21
AU596296B2 (en)	1990-04-26
HK19595A (en)	1995-02-17
DK238588A (da)	1988-11-05
JP2721507B2 (ja)	1998-03-04
DE3883606T2 (de)	1994-01-20
JPS63284126A (ja)	1988-11-21
ES2058272T3 (es)	1994-11-01
PH23901A (en)	1989-12-18
ZA883115B (en)	1990-01-31
AU1553388A (en)	1988-11-10

Similar Documents

Publication	Publication Date	Title
DE3883606D1 (de)	1993-10-07	Verwendung von Fluoxetin zur Behandlung des Diabetes.
DE3878627D1 (de)	1993-04-01	Zusammensetzung zur oberflaechenbehandlung von kautschuk.
ATE225176T1 (de)	2002-10-15	Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
DE3584013D1 (de)	1991-10-10	Zubereitung zur behandlung von psoriasis.
DE3884622D1 (de)	1993-11-04	Schmiermittelzubereitung zur behandlung von rheuma.
DE69530403D1 (de)	2003-05-22	Analogen des keratinozytenwachstumfaktors
DE69013999D1 (de)	1994-12-15	Siliconkautschukzusammensetzung zur Behandlung von Faserstrukturen.
DE3884895D1 (de)	1993-11-18	Verwendung von Bezafibrat zur Behandlung von Diabetes.
DE69325029D1 (de)	1999-06-24	Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus
DE3681642D1 (de)	1991-10-31	Benzopyran-verbindungen zur behandlung von inkontinenz.
ATE106736T1 (de)	1994-06-15	Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
DE3871791D1 (de)	1992-07-09	Verwendung von homo- und copolymeren des vinylalkohols zum tablettieren von wirkstoffen.
DE3680507D1 (de)	1991-08-29	Verwendung von oxirancarbonsaeuren zur behandlung der hyperlipaemie.
DE3875016D1 (de)	1992-11-05	Therapeutikum zur behandlung von aids.
DE3781667D1 (de)	1992-10-15	Verwendung von 24,25-dihydroxycholecalciferol zur verhuetung des knochenalterns.
ATE59780T1 (de)	1991-01-15	Pharmazeutische zusammensetzung zur behandlung von tumoren.
DE3584926D1 (de)	1992-01-30	Behandlung von oedemen mit hohem proteingehalt durch direktes aufbringen von benzopyronen.
ATE45675T1 (de)	1989-09-15	Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
PT80152B (de)	1987-04-07	Methode zur behandlung des glaukoms vok
DE3787954D1 (de)	1993-12-02	Verwendung von 5-(Subst. Phenyl)- Oxazolidinonderivaten zur Behandlung von Depressionen.
DE3686688D1 (de)	1992-10-15	Verwendung von sulfanilamido quinoxalinen zur behandlung von neoplastischen krankheiten.
DE3684825D1 (de)	1992-05-21	Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
DE3675720D1 (de)	1991-01-03	Behandlung von material aus lignocellulose.
DE3583337D1 (de)	1991-08-01	Zusammensetzung zur behandlung von haemorroiden.
DE3688742D1 (de)	1993-08-26	2,2-diphenoxy-n,n-dimethylaminoaethan zur verbesserung der sauerstoffversorgung des gehirns.

Legal Events

Date	Code	Title	Description
1994-04-15	UEP	Publication of translation of european patent specification
2002-01-15	REN	Ceased due to non-payment of the annual fee